Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $10.6 Million - $18.1 Million
55,432 New
55,432 $18.1 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $15.6 Million - $28.8 Million
134,243 Added 158.8%
218,781 $41.8 Million
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $10.8 Million - $17.5 Million
84,538 New
84,538 $17.5 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $34 Million - $52.1 Million
-258,419 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$92.73 - $142.05 $23.1 Million - $35.4 Million
-249,537 Reduced 49.13%
258,419 $33.7 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $28.2 Million - $43.4 Million
418,660 Added 468.85%
507,956 $52.7 Million
Q3 2020

Nov 16, 2020

BUY
$42.79 - $75.8 $3.82 Million - $6.77 Million
89,296 New
89,296 $6.77 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.